ESElias Smirlis

Elias Smirlis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elias Smirlis has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Babajide Adio

    Internal Medicine, MercyOne North Iowa Medical Center, Mason City, USA

    2 shared publications
  • Jacob Obholz

    Internal Medicine, MercyOne North Iowa Medical Center, Mason City, USA

    2 shared publications
  • Tara Eineichner

    Internal Medicine Residency, MercyOne North Iowa Medical Center, Mason City, USA

    2 shared publications

Latest Publications

  • Open Access

    A Case of Suspected Statin-Related Delayed Onset Necrotizing Myositis

    by Elias Smirlis, Jacob Obholz, Tara Eineichner, Babajide Adio

    Statin-induced necrotizing myositis is a rare subtype of idiopathic inflammatory myopathies due to the production of an antibody to the 200/100 kDA protein complex which was subsequently found to be directed against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). Similar to other auto-immune necrotizing myopathies, the disease is characterized by proximal muscle weakness, significant serum creatine kinase elevations, and histological evidence of necrosis of myocytes. However, there is often little to no infiltration of inflammatory cells noted on muscle biopsy. As the name implies, this subtype of idiopathic inflammatory myopathy is provoked by statin use which may be a helpful finding during the history-taking process when developing a differential diagnosis. Below, we discuss a case of a 52-year-old female with delayed-onset immune-mediated necrotizing myopathy secondary to statin use.


  • Open Access

    A Case of Suspected Statin-Related Delayed Onset Necrotizing Myositis

    by Elias Smirlis, Jacob Obholz, Tara Eineichner, Babajide Adio

    Statin-induced necrotizing myositis is a rare subtype of idiopathic inflammatory myopathies due to the production of an antibody to the 200/100 kDA protein complex which was subsequently found to be directed against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). Similar to other auto-immune necrotizing myopathies, the disease is characterized by proximal muscle weakness, significant serum creatine kinase elevations, and histological evidence of necrosis of myocytes. However, there is often little to no infiltration of inflammatory cells noted on muscle biopsy. As the name implies, this subtype of idiopathic inflammatory myopathy is provoked by statin use which may be a helpful finding during the history-taking process when developing a differential diagnosis. Below, we discuss a case of a 52-year-old female with delayed-onset immune-mediated necrotizing myopathy secondary to statin use.